|4Mar 3, 4:10 PM ET

Adams Jennifer McKie 4

4 · Eton Pharmaceuticals, Inc. · Filed Mar 3, 2023

Insider Transaction Report

Form 4
Period: 2023-03-03
Transactions
  • Award

    Stock Option (Right to buy)

    2023-03-03+25,000103,133 total
    Exercise: $3.47Exp: 2033-02-19Common Stock (25,000 underlying)
Footnotes (2)
  • [F1]Option was approved by the Compensation Committee of the Board of Directors as of February 20, 2023 and approved by the full Board of Directors on March 3, 2023.
  • [F2]The shares subject to the option shall vest on a quarterly basis over 12 months from the date of grant until fully vested on February 20, 2024.

Documents

1 file
  • 4
    ownership.xmlPrimary